NasdaqCM - Delayed Quote USD

Talis Biomedical Corporation (TLIS)

9.00 -0.10 (-1.10%)
At close: April 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
412.00
412.00
3,652.00
--
--
Cost of Revenue
41.00
41.00
8,391.00
--
--
Gross Profit
371.00
371.00
-4,739.00
--
--
Operating Expense
67,186.00
67,186.00
110,400.00
191,816.00
91,184.00
Operating Income
-66,815.00
-66,815.00
-115,139.00
-191,816.00
-91,184.00
Net Non Operating Interest Income Expense
--
--
--
--
54.00
Other Income Expense
4,808.00
4,808.00
2,127.00
-220.00
54.00
Pretax Income
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Net Income Common Stockholders
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Diluted NI Available to Com Stockholders
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Basic EPS
-34.12
--
-62.77
-109.08
-69.46
Diluted EPS
-34.12
--
-62.77
-109.08
-69.46
Basic Average Shares
1,817.51
--
1,800.45
1,760.54
1,311.99
Diluted Average Shares
1,817.51
--
1,800.45
1,760.54
1,311.99
Total Operating Income as Reported
-66,815.00
-66,815.00
-115,139.00
-191,816.00
-91,184.00
Total Expenses
67,227.00
67,227.00
118,791.00
191,816.00
91,184.00
Net Income from Continuing & Discontinued Operation
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Normalized Income
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Interest Income
--
--
--
--
54.00
Net Interest Income
--
--
--
--
54.00
EBIT
-66,815.00
-66,815.00
-115,139.00
-191,816.00
-91,184.00
EBITDA
-66,045.00
-66,045.00
-106,309.00
-190,238.00
-90,421.00
Reconciled Cost of Revenue
41.00
41.00
8,391.00
--
--
Reconciled Depreciation
770.00
770.00
8,830.00
1,578.00
763.00
Net Income from Continuing Operation Net Minority Interest
-62,007.00
-62,007.00
-113,012.00
-192,036.00
-91,130.00
Normalized EBITDA
-66,045.00
-66,045.00
-106,309.00
-190,238.00
-90,421.00
12/31/2020 - 2/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EUZ.DE Eckert & Ziegler SE
36.04
-1.26%
 
BJDX Bluejay Diagnostics, Inc.
0.5510
-9.67%
 
BBLGW Bone Biologics Corporation
23.04
+15.14%
 
TIVC Tivic Health Systems, Inc.
1.0700
-3.60%
 
AIMD Ainos, Inc.
1.0400
-0.95%
 
BBLG Bone Biologics Corporation
1.5200
-1.94%
 
VERO Venus Concept Inc.
0.7688
+6.64%
 
NAOV NanoVibronix, Inc.
0.7500
0.00%
 
VAPO Vapotherm, Inc.
1.2564
-0.76%
 
MOTS Motus GI Holdings, Inc.
0.0800
+3.90%